Table 2 Baseline characteristics of the included studies
Study ID | General characteristics | Medical history | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex (Male), N (%) | Age (Years), Mean ± SD | BMI, Mean ± SD | Smoking (Current), N (%) | Hypertension, N (%) | Diabetes, N (%) | Hyperlipidemia, N (%) | Myocardial infarction, N (%) | Chronic heart failure, N (%) | Renal disease, N (%) | |||
STEMI | NSTEMI | |||||||||||
Thiele et al. 2023 | ECMO | 170 (81.3) | 62.3 ± 9.7 | 27.3 ± 3.7 | 74 (36.3) | 118 (57) | 70 (33.7) | 55 (26.6) | 23 (11.1) | NA | NA | |
Standard Care | 169 (81.2) | 63.7 ± 10.5 | 28 ± 4.5 | 71 (34.5) | 115 (55.8) | 60 (29.1) | 74 (35.9) | 31 (15.0) | NA | NA | ||
Ostadal et al. 2022 (ECMO-CS) | ECMO | 43 (74.1) | 67 ± 10.6 | NA | 14 (25.9) | 35 (62.5) | 16 (28.6) | NA | 30 (51.7) | 7 (12.1) | 14 (25.0) | 7 (12.5) |
Standard Care | 43 (72.9) | 64.7 ± 9.9 | NA | 27 (47.4) | 38 (65.5) | 21 (36.2) | NA | 29 (49.2) | 7 (11.9) | 13 (22.4) | 9 (15.8) | |
Banning et al. 2023 (EURO SHOCK) | ECMO | 13 (81.3) | 66 ± 9 | 27 ± 5 | 4 (28.6) | 10 (66.7) | 7 (50) | 6 (66.7) | 0 (0) | 1 (6.7) | 0 (0) | 1 (7.7) |
Standard Care | 16 (88.9) | 65 ± 12 | 28 ± 4 | 6 (35.3) | 10 (71.4) | 5 (31.3) | 7 (87.5) | 1 (6.7) | 2 (13.3) | 0 (0) | 4 [25] | |
Lackermair et al. 2020 (ECLS-Shock-I) | ECMO | 16 (76.2) | 60 ± 14.3 | 26.6 ± 2.5 | 9 (45) | 11 (55) | 3 [15] | 5 [25] | 13 (61.9) | 8 (38.1) | NA | NA |
Standard Care | 20 (95) | 68 ± 11.1 | 27.3 ± 4.8 | 11 (55) | 15 (75) | 6 [30] | 10 (50) | 8 (38.1) | 13 (61.9) | NA | NA | |
Study ID | Clinical Parameters | |||||||||||
Heart rate (beat/min), Mean ± SD | Blood pressure (mm Hg), Mean ± SD | Prior PCI, N (%) | Prior CABG, N (%) | Serum lactate (mmol/L), Mean ± SD | Serum creatinine (mg/dl), Mean ± SD | Infarct-related artery, N (%) | ||||||
Systolic | Diastolic | Left coronary artery | Left anterior descending | Left circumflex | Right coronary artery | |||||||
Thiele et al. 2023 | ECMO | 91.7 ± 26 | 98.3 ± 29.9 | 61.3 ± 17.2 | 27 (13.0) | 5 (2.4) | 7 ± 3.8 | 1.2 ± 0.4 | 20 (9.9) | 95 (46.8) | 36 (17.7) | 52 (25.6) |
Standard Care | 92 ± 29 | 99 ± 29.9 | 60.3 ± 15.7 | 43 (20.9) | 6 (2.9) | 7.2 ± 4 | 1.2 ± 0.37 | 20 (10.0) | 97 (48.5) | 35 (17.5) | 48 (24.0) | |
Ostadal et al. 2022 (ECMO-CS) | ECMO | 110 ± 32.22 | 86.3 ± 11.4 | NA | NA | NA | 5.6 ± 4 | NA | NA | NA | NA | NA |
Standard Care | 100 ± 20.7 | 91.2 ± 19.4 | NA | NA | NA | 5.1 ± 3.1 | NA | NA | NA | NA | NA | |
Banning et al. 2023 (EURO SHOCK) | ECMO | N/A | 90 ± 23 | 55 ± 15 | 2 (13.3) | 0 (0) | 5.9 ± 3.7 | 1.2 ± 0.4 | 2 (12.5) | 7 (43.75) | 2 (12.5) | 5 (31.3) |
Standard Care | N/A | 107 ± 38 | 68 ± 27 | 5 (31.3) | 1 (6.3) | 8.2 ± 4.6 | 1.5 ± 0.5 | 4 (22.2) | 8 (44.4) | 1 (5.6) | 4 (22.2) | |
Lackermair et al. 2020 (ECLS-Shock-I) | ECMO | 83.3 ± 23.9 | 116.7 ± 23.9 | 71.3 ± 12.7 | 4 [20] | 0 (0) | 5.3 ± 4.6 | 1.3 ± 0.2 | 1 (5%) | 15 (72%) | 2 (10%) | 3 (14%) |
Standard Care | 80.7 ± 22.3 | 102.7 ± 19.1 | 66 ± 18.3 | 4 [20] | 0 (0) | 6 ± 4.7 | 1.3 ± 0.2 | 3 (14%) | 8 (38%) | 5 (24%) | 5 (24%) | |